US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuo Therapeutics, Inc.

1.50

0.0000

Volume:- -

Turnover:- -

Market Cap:72.12M

PE:-28.25

High:1.50

Open:1.50

Low:1.50

Close:1.50

52wk High:3.23

52wk Low:0.9359

Shares:48.08M

Float Shares:22.86M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0531

EPS(LYR):-0.0293

ROE:-1032.50%

ROA:-103.65%

PB:-75.39

PE(LYR):-51.28

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Roth MKM Reaffirms Their Buy Rating on Nuo Therapeutics (AURX)

Nuo Therapeutics FY25 net loss widens to $2.5 million; revenue climbs to $3.3 million

Nuo Therapeutics Secures $1.6 Million Loan from Group of Lenders

Nuo Therapeutics Inc. Held Annual Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AURX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AURX\",,,,,undefined,":{"symbol":"AURX","market":"US","secType":"STK","nameCN":"Nuo Therapeutics, Inc.","latestPrice":1.5,"timestamp":1776369600000,"preClose":1.5,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":22864200,"shares":48077700,"eps":-0.053098,"marketStatus":"Not Yet Opened","change":0,"latestTime":"04-16 16:00:00 EDT Delay","open":1.5,"high":1.5,"low":1.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.053098,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":1.5,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AURX\",,,,,undefined,":{"symbol":"AURX","floatShares":22864200,"roa":"-103.65%","roe":"-1032.50%","lyrEps":-0.029253,"shares":48077700,"dividePrice":0,"high":1.5,"amplitude":0,"preClose":1.5,"low":1.5,"week52Low":0.9359,"pbRate":"-75.39","psRate":"21.76","week52High":3.23,"institutionHeld":0,"latestPrice":1.5,"eps":-0.053098,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.053098,"open":1.5,"prevYearClose":1.97,"prevWeekClose":1.7,"prevMonthClose":1.45,"prevQuarterClose":1.45,"fiveDayClose":1.7,"twentyDayClose":1.39,"sixtyDayClose":1.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AURX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-12","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-19","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713499200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-20","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1700456400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AURX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1765857600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AURX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627934422","title":"Roth MKM Reaffirms Their Buy Rating on Nuo Therapeutics (AURX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627934422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627934422?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:15","pubTimestamp":1776201332,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Kyle Bauser reiterated a Buy rating on Nuo Therapeutics today and set a price target of $3.00. According to TipRanks, Bauser is an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-nuo-therapeutics-aurx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-nuo-therapeutics-aurx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324105","title":"Nuo Therapeutics FY25 net loss widens to $2.5 million; revenue climbs to $3.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324105","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324105?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:45","pubTimestamp":1774907128,"startTime":"0","endTime":"0","summary":"Nuo Therapeutics posted a net loss of about $2.5 million for fiscal 2025.Revenue climbed to about $3.3 million, including $0.2 million of distribution fee revenue from Smith+Nephew.Gross margin narrowed to about 67% from about 78% a year earlier.Product revenue more than doubled to about $3.1 million, driven by an expanding Aurix customer base and initial Smith+Nephew private-label sales in the second half.Smith+Nephew distribution agreement includes minimum annual purchase commitments averaging about $0.5 million during the initial term starting October 2025; management expects related revenue to increase modestly over the next 12 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original conte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL1V4cvD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606226722","title":"Nuo Therapeutics Secures $1.6 Million Loan from Group of Lenders","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226722","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226722?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:26","pubTimestamp":1769462804,"startTime":"0","endTime":"0","summary":"Nuo Therapeutics Inc. has entered into a new Loan and Security Agreement with four lenders, providing for loans totaling up to $1.6 million. The agreement includes an initial funding of $1.0 million, which closed on January 23, 2026, and a potential second funding of $600,000 available on September 30, 2026, subject to certain conditions. The loans are secured by a lien on all of the company's assets, including its intellectual property. Nuo Therapeutics plans to use the proceeds for general working capital purposes. As part of the deal, the company also issued warrants to the lenders to purchase shares of its common stock, with additional warrants to be issued as payment for accrued interest. Notably, two of the lenders are significant shareholders and insiders of the company.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL8btBRL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592117839","title":"Nuo Therapeutics Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592117839","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592117839?lang=en_us&edition=fundamental","pubTime":"2025-12-18 00:09","pubTimestamp":1765987795,"startTime":"0","endTime":"0","summary":"Nuo Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on December 16, 2025. At the meeting, stockholders elected David E. Jorden, Paul D. Mintz, Scott M. Pittman, and C. Eric Winzer to the board of directors. Stockholders also ratified the appointment of MaloneBailey LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. All proposals considered at the meeting were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely respon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL5YByhZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AURX\",params:#limit:6,delay:false,,,undefined,":[]}}